[177Lu]LuFAPI-46 | m-entrepreneurship.com

Product Name :
[177Lu]LuFAPI-46

Search keywords :
FAPI-46

drugId :
null

Target Vo:
Prolyl endopeptidase FAP

Target Vo Short Name :
FAP

Moa_Name:
Fibroblast activation protein alpha inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Osaka University

Active Company_Name :
Osaka University

Active Indication_Name:
Pancreatic Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cathepsin B Rabbit mAb custom synthesis
Anti-6X His-tag (C-terminal) Mouse mAb Protocol
MLH1 Antibody (YA703): MLH1 Antibody (YA703) is a non-conjugated and Mouse origined monoclonal antibody about 85 kDa, targeting to MLH1 (4C1). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Monkey.

Author: Betaine hydrochloride

Related Posts